NeuBase Therapeutics Inc logo

NeuBase Therapeutics Inc

NEW
NAS:NBSE (USA)  
$ 0.38 -0.012499 (-3.2%) 10:08 PM EST
At Loss
Enterprise V:
$ -5.82M
Volume:
-
Avg Vol (2M):
-
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
-

Business Description

Description
NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington's Disease, Myotonic Dystrophy and Familial Parkinson's Disease among others.
Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 21.24
9-Day RSI 27.82
14-Day RSI 30.84
6-1 Month Momentum % -37.7
12-1 Month Momentum % -89.41

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History
Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2024-11-08 Est.)

NBSE's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:NBSE

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

NeuBase Therapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -7.7
Beta 0
Volatility % 110.28
14-Day RSI 30.84
14-Day ATR ($) 0.019023
20-Day SMA ($) 0.391725
12-1 Month Momentum % -89.41
52-Week Range ($) 0.36 - 4.44
Shares Outstanding (Mil) 3.75

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

NeuBase Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

NeuBase Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

NeuBase Therapeutics Inc Frequently Asked Questions

What is NeuBase Therapeutics Inc(NBSE)'s stock price today?
The current price of NBSE is $0.38. The 52 week high of NBSE is $4.44 and 52 week low is $0.36.
When is next earnings date of NeuBase Therapeutics Inc(NBSE)?
The next earnings date of NeuBase Therapeutics Inc(NBSE) is 2024-11-08 Est..
Does NeuBase Therapeutics Inc(NBSE) pay dividends? If so, how much?
NeuBase Therapeutics Inc(NBSE) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1